KRAS G12C NSCLC models are sensitive to direct targeting of...

Main
2018 / 10
KRAS G12C NSCLC models are sensitive to direct targeting of...

Clinical Cancer Research 2018 / 10

KRAS G12C NSCLC models are sensitive to direct targeting of KRAS in combination with PI3K inhibition.

Misale, Sandra, Fatherree, Jackson P, Cortez, Eliane, Li, Chendi, Bilton, Samantha J, Timonina, Daria, Lee, Dana, Gomez-Caraballo, Maria, Greenberg, Max, Nangia, Varuna, Greninger, Patricia, Egan, Reg

How much do you like this book?

What’s the quality of the file?

Download the book for quality assessment

What’s the quality of the downloaded files?

Language:

english

Journal:

Clinical Cancer Research

DOI:

10.1158/1078-0432.ccr-18-0368

Date:

October, 2018

File:

PDF, 5.74 MB

english, 2018

Conversion to is in progress

Conversion to is failed